Jiu An Medical (002432.SZ): No separate charges for AI business, revenue from diabetes diagnosis and treatment care business accounts for a low proportion.

Wisdom Financial News APP reported that Jiuan Medical (002432.SZ) issued a stock price abnormal movement announcement, stating that the company's diabetes diagnosis and treatment care business and the "AIoT Diabetes Family Medical Assistant" project involve the application of AI tools, which helps improve medical efficiency and effectiveness, reduce medical costs. The above-mentioned tools are not charged separately, and the purpose of conducting related projects is to help the diabetes diagnosis and treatment care business achieve cost reduction and efficiency improvement, and do not constitute a separate main business segment. In the full year of 2025, the company's diabetes diagnosis and treatment care business related revenue is approximately 122 million yuan, accounting for 8.93% of the company's 2025 annual revenue, a relatively low proportion that does not have a significant impact on the company's performance, and there is uncertainty about future revenue in this business.